FR2365588A1 - Procede de preparation d'androstanones-17 - Google Patents

Procede de preparation d'androstanones-17

Info

Publication number
FR2365588A1
FR2365588A1 FR7721932A FR7721932A FR2365588A1 FR 2365588 A1 FR2365588 A1 FR 2365588A1 FR 7721932 A FR7721932 A FR 7721932A FR 7721932 A FR7721932 A FR 7721932A FR 2365588 A1 FR2365588 A1 FR 2365588A1
Authority
FR
France
Prior art keywords
androstanone
formula
alkyl radical
androstanones
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7721932A
Other languages
English (en)
French (fr)
Other versions
FR2365588B1 (2
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2365588A1 publication Critical patent/FR2365588A1/fr
Application granted granted Critical
Publication of FR2365588B1 publication Critical patent/FR2365588B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7721932A 1976-07-16 1977-07-18 Procede de preparation d'androstanones-17 Granted FR2365588A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (2)

Publication Number Publication Date
FR2365588A1 true FR2365588A1 (fr) 1978-04-21
FR2365588B1 FR2365588B1 (2) 1982-06-25

Family

ID=5983514

Family Applications (4)

Application Number Title Priority Date Filing Date
FR7721932A Granted FR2365588A1 (fr) 1976-07-16 1977-07-18 Procede de preparation d'androstanones-17
FR7806455A Pending FR2372175A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17
FR7806457A Pending FR2372176A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de derives d'alcoxy-3 androstanones-17
FR7806456A Pending FR2372174A1 (fr) 1976-07-16 1978-03-07 Procede de preparation d'alcoxy-3 hydroxy-17 androstanes

Family Applications After (3)

Application Number Title Priority Date Filing Date
FR7806455A Pending FR2372175A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17
FR7806457A Pending FR2372176A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de derives d'alcoxy-3 androstanones-17
FR7806456A Pending FR2372174A1 (fr) 1976-07-16 1978-03-07 Procede de preparation d'alcoxy-3 hydroxy-17 androstanes

Country Status (18)

Country Link
US (1) US4179336A (2)
JP (1) JPS5315493A (2)
AT (1) AT363196B (2)
BE (1) BE856860A (2)
CH (3) CH627190A5 (2)
CS (1) CS200517B2 (2)
DD (4) DD136141A5 (2)
DE (1) DE2632677A1 (2)
DK (1) DK142372C (2)
FR (4) FR2365588A1 (2)
GB (1) GB1585786A (2)
HU (4) HU182790B (2)
IE (1) IE45304B1 (2)
IT (1) IT1077339B (2)
NL (1) NL7706638A (2)
SE (1) SE440779B (2)
SU (1) SU980628A3 (2)
YU (1) YU164277A (2)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
EP0738703B1 (en) * 1995-02-28 2002-05-22 Nippon Shokubai Co., Ltd. Acrylic acid derivatives, method for preparing the acrylic acid derivatives, and acrylic acid polymers
TR201907313T4 (tr) * 2003-05-23 2019-06-21 Nektar Therapeutics İki PEG zinciri içeren PEG türevleri.
CN102656153B (zh) * 2009-10-29 2015-02-18 延世大学校产学协力团 新型血管渗漏阻断剂
WO2012116290A2 (en) 2011-02-25 2012-08-30 Washington University Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
CN119192266A (zh) 2011-10-14 2024-12-27 萨奇治疗股份有限公司 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
MX365644B (es) 2012-12-18 2019-06-10 Univ Washington Esteroides neuroactivos sustituidos con 19-alcoxi-17, profarmacos de los mismos, y metodos de tratamiento usando los mismos.
EP2956466A4 (en) 2013-02-15 2016-11-02 Univ Washington NEUROACTIVE ENANTIOMERS 15, 16 AND 17 SUBSTITUTED STEROIDS AS MODULATORS FOR GABA-A RECEPTORS
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
JP6470258B2 (ja) 2013-04-17 2019-02-13 セージ セラピューティクス， インコーポレイテッド １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法
ES2807264T3 (es) 2013-04-17 2021-02-22 Sage Therapeutics Inc Esteroides neuroactivos 19-nor para métodos de tratamiento
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2015010054A2 (en) 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
ES2848823T3 (es) 2013-08-23 2021-08-12 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
ME03809B (me) 2014-10-16 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
US10577390B2 (en) 2014-10-16 2020-03-03 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2016123056A1 (en) 2015-01-26 2016-08-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP4155314A1 (en) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
CR20240234A (es) 2019-05-31 2024-07-09 Sage Therapeutics Inc ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319650A1 (fr) * 1975-08-01 1977-02-25 Schering Ag Procede de preparation de derives de la 5-androstene-17-one et utilisation de ces substances

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (2) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
US3738983A (en) * 1971-08-06 1973-06-12 Searle & Co Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319650A1 (fr) * 1975-08-01 1977-02-25 Schering Ag Procede de preparation de derives de la 5-androstene-17-one et utilisation de ces substances

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1976 *

Also Published As

Publication number Publication date
IE45304B1 (en) 1982-07-28
SE7708192L (sv) 1978-01-17
HU182790B (en) 1984-03-28
DE2632677C2 (2) 1988-06-16
BE856860A (fr) 1978-01-16
FR2372176A1 (fr) 1978-06-23
GB1585786A (en) 1981-03-11
YU164277A (en) 1982-08-31
JPS6117477B2 (2) 1986-05-07
FR2372174A1 (fr) 1978-06-23
SE440779B (sv) 1985-08-19
US4179336A (en) 1979-12-18
DD137235A5 (de) 1979-08-22
DE2632677A1 (de) 1978-01-26
DD132439A5 (de) 1978-09-27
HU182681B (en) 1984-02-28
AT363196B (de) 1981-07-10
CH629222A5 (de) 1982-04-15
FR2365588B1 (2) 1982-06-25
DD136141A5 (de) 1979-06-20
SU980628A3 (ru) 1982-12-07
DK142372C (da) 1981-03-23
HU182789B (en) 1984-03-28
CS200517B2 (en) 1980-09-15
HU179344B (en) 1982-10-28
FR2372175A1 (fr) 1978-06-23
NL7706638A (nl) 1978-01-18
DK323677A (da) 1978-01-17
DD136142A5 (de) 1979-06-20
DK142372B (da) 1980-10-20
CH629503A5 (de) 1982-04-30
CH627190A5 (2) 1981-12-31
ATA504677A (de) 1980-12-15
IE45304L (en) 1978-01-16
IT1077339B (it) 1985-05-04
JPS5315493A (en) 1978-02-13

Similar Documents

Publication Publication Date Title
FR2365588A1 (fr) Procede de preparation d'androstanones-17
CA2164638A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2387658A1 (fr) Procede pour combattre les microorganismes
EP1245249A3 (fr) Utilisation d'un composé amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
BE901224A (fr) Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation.
FR2411179A1 (fr) Nouveaux derives de l'acide 2-(4-thio-2-oxoazetidine-1-yl)-3-methyl-crotonique et procedes pour leur preparation
CA2036876A1 (fr) Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH0641412B2 (ja) プロリンヒドロキシラーゼおよびリジンヒドロキシラーゼ抑制のための薬剤
BE904945A (fr) Nouveaux derives du thiazole, leur preparation et leur utilisation en therapeutique.
FR2426694A1 (fr) Cephalosporines perfectionnees, leur procede de preparation et leur application therapeutique
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
CA2023645A1 (fr) Procede pour la preparation enantioselective de derives de la phenylisoserine
FR2401913A1 (fr) Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant
CA2128359A1 (fr) Nouveaux derives de benzospiroalcene leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR860008973A (ko) 2-피롤리돈 유도체
BE904641A (fr) 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers.
FR2397425A1 (fr) Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
BE904983A (fr) Acides propenylaminothiazolylcephalosporaniques 3-substitues et leurs esters.
FR2402011A1 (fr) Procede de preparation de p-benzoquinone-diacetals par oxydation anodique du benzene ou d'un alcoxy-benzene en presence de methanol
BE901278A (fr) Derives de 4,5,6,7-tetrahydrothiazolo [5,4-c] pyridine, procedes pour les preparer et medicament les contenant.
BE905654A (fr) Derives de la armstrong 2-1,2,4-triazoline-5-one, procede pour leur preparation et leurs utilisations.
ES447882A1 (es) Procedimiento para la preparacion de agentes bactericidas y fungicidas.
BE1000719A4 (fr) Derives de 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant.
KR880013562A (ko) 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물
BE1002696A3 (fr) Derives de dioxazocine, leur procede de preparation et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
ST Notification of lapse